P53 status plays no role in radiosensitizing effects of SN-38, a camptothecin derivative

Cancer Chemotherapy and Pharmacology

Volumn 45, Issue 5, 2000, Pages 362-368

  Xie, Xuejun ^a,c   Sasai, Keisuke ^a   Shibuya, Keiko ^a   Tachiiri, Seiji ^a   Nihei, Keij ^a   Ohnishi, Takeo ^b   Hiraoka, Masahiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Camptothecin; CPT 11; p53; Radiation; SN 38

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; CAMPTOTHECIN DERIVATIVE; DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; IRINOTECAN; LIPOCORTIN 5; PROTEIN P53; RADIOSENSITIZING AGENT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CELL CYCLE; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; FIBROBLAST CULTURE; FLOW CYTOMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIZATION; WESTERN BLOTTING;

EID: 0034088094     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051003     Document Type: Article

References (44)

1. 1. Boothman DA, Trask DK, Pardee AB (1989) Inhibition of potentially lethal DNA damage repair in human tumor cells by β-Lapachone, an activator of topoisomerase I. Cancer Res 49: 605
2. 2. Boothman DA, Wang M, Schea RA, Burrows HL, Strickfaden S, Owens JK (1992) Posttreatment exposure to camptothecin enhances the lethal effects of x-rays on radioresistant human malignant melanoma cells. Int J Radiat Oncol Biol Phys 24: 939
3. 3. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849
4. 4. D'Arpa P, Beardmore C, Liu LF (1990) Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. Cancer Res 50: 6919
5. 5. Del Bino G, Bruno S, Yi PN, Darzynkiewicz Z (1992) Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation. Cell Prolif 25: 537
6. 6. Drewinko B, Freireich E, Gottlieb J (1974) Lethal activity of camptothecin sodium on human lymphoma cells. Cancer Res 34: 747
7. 7. Falk SJ, Smith PJ (1992) DNA damaging and cell cycle effects of the topoisomerase I poison camptothecin in irradiated human cells. Int J Radiat Biol 61: 749
8. 8. Fan S, El-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace AJJ, Magrath I, Kohn KW, O'Connor PM (1994) p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 54: 5824
9. 9. Fan S, Smith ML, Rivet DJ, Duba D, Zhan Q, Kohn KW, Fornace AJ, O'Connor PM (1995) Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res 55: 1649
10. 10. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang W-W, Owen-Schaub LB, Roth JA (1994) Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 54: 2287
11. 11. Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJJ, Giaccia AJ (1994) Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 14: 6264
12. 12. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors Nature 379: 88
13. 13. Horwitz SB, Horwitz MS (1973) Effects of camptothecin on the breakage and repair of DNA during the cell cycle. Cancer Res 33: 2834
14. 14. Huang T-S, Kuo M-L, Shew J-Y, Chou Y-W, Yang WK (1996) Distinct p53-mediated G1/S checkpoint responses in two NIH3T3 subclone cells following treatment with DNA-damaging agents. Oncogene 13: 625
15. 15. Jansen WJ, Zwart B, Hulscher ST, Giaccone G, Pinedo HM, Boven E (1997) CPT-11 in human colon-cancer cell line and xenografts: characterization of cellular sensitivity determinants. Int J Cancer 70: 335
16. 16. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304
17. 17. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89: 7491
18. 18. Lee JM, Bernstein A (1993) p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci U S A 90: 5742
19. 19. Lee JM, Bernstein A (1995) Apoptosis, cancer and the p53 tumour suppressor gene. Cancer Metastasis Rev 14: 149
20. 20. Li C-Y, Nagasawa H, William K, Dahlberg, Little JB (1995) Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines. Oncogenetics 11: 1885
21. 21. Li LH, Fraser TJ, Olin EJ, Bhuyan BK (1972) Action of camptothecin on mammalian cells in culture. Cancer Res 32: 2643
22. 22. Lin D, Shield S, MT, Ullrich SJ, Appella E, Mercer WE (1992) Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Proc Natl Acad Sci USA 89: 9210
23. 23. Little JB (1968) Delayed initiation of DNA synthesis in irradiated human diploid cells. Nature 218: 1064
24. 24. Little JB, Nagasawa H, Keng PC, Yu YJ, Li C-Y (1995) Absence of radiation-induced G1 arrest in two closely related human lymphoblast cell lines that differ in p53 status. J Biol Chem 270: 11033
25. 25. Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957
26. 26. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847
27. 27. Matsumoto H, Takahashi A, Wang X, Ohnishi K, Ohnishi T (1997) Transfection of p53-knockout mouse fibroblasts with wild-type p53 increases the thermosensitivity and stimulates apoptosis induced by heat stress. Int J Radiat Oncol Biol Phys 39: 197
28. 28. Mattern MR, Hofmann GA, McCabe FL, Johnson RK (1991) Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864). Cancer Res 51: 5813
29. 29. Michalovitz D, Halevy O, Oren M (1990) Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62: 671
30. 30. Müller H, Eppenberger U (1996) The dual role of mutant p53 protein in chemosensitivity of human cancers. Anticancer Res 16: 3845
31. 31. Musk SRR, Steel GG (1990) The inhibition of cellular recovery in human tumor cells by inhibitors of topoisomerase. Br J Cancer 62: 364
32. 32. Nagasawa H, Li CY, Maki CG, Imrich AC, Little JB (1995) Relationship between radiation-induced G1 phase arrest and p53 function in human tumor cells. Cancer Res 55: 1842
33. 33. Ng CE, Bussey AM, Raaphorst GP (1994) Inhibition of potentially lethal and sublethal damage repair by camptothecin and etoposide in human melanoma cell lines. Int J Radiat Biol 66: 49
34. 34. Omura M, Torigoe S, Kubota N (1997) SN-38, a metabolite of the camptothecin derivative CPT-11, potentiates the cytotoxic effect of radiation in human colon adenocarcinoma cells grown as spheroids. Radiother Oncol 43: 197
35. 35. Rivory LP (1996) Irinotecan (CPT-11): a brief overview. Clin Exp Pharmacol Physiol 23: 1000
36. 36. Sasai K, Guo GZ, Shibuya K, Oya N, Shibata T, Nagata Y, Hiraoka M (1998) Effects of SN-38 (an active metabolite of CPT-11) on responses of human and rodent cells to irradiation. Int J Radiat Oncol Biol Phys 42: 785
37. 37. Sellins KS, Cohen JJ (1987) Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 139: 3199
38. 38. Sliche N, Myer WJ, Nelson WG, Slebos RJ, Kastan MB (1993) Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res 53: 4164
39. 39. Tamura K, Takada M, Kawase I, Tada T, Kudoh S, Okishio K, Fukuoka M, Yamaoka N, Fujiwara Y, Yamakido M (1997) Enhancement of tumor radio-response by irinotecan in human lung tumor xenograft. Jpn J Cancer Res 88: 218
40. 40. Terasima T, Tolmach LJ (1963) Variations in several responses of Hela cells to X-irradiation during the division cycle. Biophys J 3: 11
41. 41. Vasey PA, Jones NA, Jenkins S, Dive C, Brown R (1996) Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance. Mol Pharmacol 50: 1536
42. 42. Yonisch-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352: 345
43. 43. Yoshida A, Ueda T, Wano Y, Nakamura T (1993) DNA damage and cell killing by camptothecin and its derivative in human leukemia HL-60 cells. Jpn J Cancer Res 84: 566
44. 44. Zambetti GP, Levine AJ (1993) A comparison of the biological activities of wild-type and mutant p53. FASEB J 7: 855